180 related articles for article (PubMed ID: 2918846)
21. Normalization of low-density-lipoprotein levels in heterozygous familial hypercholesterolemia with a combined drug regimen.
Kane JP; Malloy MJ; Tun P; Phillips NR; Freedman DD; Williams ML; Rowe JS; Havel RJ
N Engl J Med; 1981 Jan; 304(5):251-8. PubMed ID: 7003391
[TBL] [Abstract][Full Text] [Related]
22. Effects of combined probucol-colestipol treatment for familial hypercholesterolemia and coronary artery disease.
Kuo PT; Wilson AC; Kostis JB; Moreyra AE
Am J Cardiol; 1986 Jun; 57(16):43H-48H. PubMed ID: 3524177
[TBL] [Abstract][Full Text] [Related]
23. Long-term effects of fenofibrate on serum lipids and on lipoprotein cholesterol in type II hyperlipoproteinemic patients.
Sommariva D; Bonfiglioli D; Pogliaghi I; Cabrini E; Fasoli A
Pharmacol Res Commun; 1984 Aug; 16(8):809-20. PubMed ID: 6593751
[TBL] [Abstract][Full Text] [Related]
24. Effects of continuous medroxyprogesterone acetate on lipoprotein metabolism in postmenopausal women receiving estrogen.
Wakatsuki A; Sagara Y
Maturitas; 1996 Aug; 25(1):35-44. PubMed ID: 8887307
[TBL] [Abstract][Full Text] [Related]
25. Colestipol plus nicotinic acid in treatment of heterozygous familial hypercholesterolaemia.
Illingworth DR; Phillipson BE; Rapp JH; Connor WE
Lancet; 1981 Feb; 1(8215):296-8. PubMed ID: 6109940
[TBL] [Abstract][Full Text] [Related]
26. Treatment of primary moderate hypercholesterolemia with lovastatin (mevinolin) and colestipol.
Vega GL; Grundy SM
JAMA; 1987 Jan; 257(1):33-8. PubMed ID: 3537351
[TBL] [Abstract][Full Text] [Related]
27. Effect of fenofibrate treatment on plasma lipoprotein lipids, high-density lipoprotein cholesterol subfractions, and apolipoproteins B, AI, AII, and E.
Knopp RH; Walden CE; Warnick GR; Albers JJ; Ginsberg J; McGinnis BM
Am J Med; 1987 Nov; 83(5B):75-84. PubMed ID: 3120587
[TBL] [Abstract][Full Text] [Related]
28. Fenofibrate affects the compositions of lipoproteins.
Goldberg AC; Schonfeld G; Anderson C; Dillingham MA
Am J Med; 1987 Nov; 83(5B):60-5. PubMed ID: 3318455
[TBL] [Abstract][Full Text] [Related]
29. Lipoprotein metabolism in postmenopausal and oophorectomized women.
Wakatsuki A; Sagara Y
Obstet Gynecol; 1995 Apr; 85(4):523-8. PubMed ID: 7898827
[TBL] [Abstract][Full Text] [Related]
30. Effects of fenofibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipoprotein peak particle size in patients with mixed hyperlipidemia.
Tribble DL; Farnier M; Macdonell G; Perevozskaya I; Davies MJ; Gumbiner B; Musliner TA
Metabolism; 2008 Jun; 57(6):796-801. PubMed ID: 18502262
[TBL] [Abstract][Full Text] [Related]
31. Primary hypercholesterolemia: effect of treatment on serum lipids, lipoprotein fractions, cholesterol absorption, sterol balance, and platelet aggregation.
Briones ER; Steiger D; Palumbo PJ; Kottke BA
Mayo Clin Proc; 1984 Apr; 59(4):251-7. PubMed ID: 6708603
[TBL] [Abstract][Full Text] [Related]
32. Enhanced low-density lipoprotein cholesterol reduction and cost-effectiveness by low-dose colestipol plus lovastatin combination therapy.
Schrott HG; Stein EA; Dujovne CA; Davidson MH; Goris GB; Oliphant TH; Phillips JC; Shawaryn GG
Am J Cardiol; 1995 Jan; 75(1):34-9. PubMed ID: 7801861
[TBL] [Abstract][Full Text] [Related]
33. Effect of fenofibrate on serum lipoproteins in subjects with familial hypercholesterolemia and combined hyperlipidemia.
Weisweiler P; Merk W; Janetschek P; Schwandt P
Atherosclerosis; 1984 Dec; 53(3):321-5. PubMed ID: 6529448
[TBL] [Abstract][Full Text] [Related]
34. Long-term maintenance of therapeutic response to lovastatin in patients with familial and non-familial hypercholesterolemia: a 3-year follow-up.
Ojala JP; Helve E; Karjalainen K; Tarkkanen A; Tikkanen MJ
Atherosclerosis; 1990 May; 82(1-2):85-95. PubMed ID: 2360923
[TBL] [Abstract][Full Text] [Related]
35. Effects of adding fenofibrate (200 mg/day) to simvastatin (10 mg/day) in patients with combined hyperlipidemia and metabolic syndrome.
Vega GL; Ma PT; Cater NB; Filipchuk N; Meguro S; Garcia-Garcia AB; Grundy SM
Am J Cardiol; 2003 Apr; 91(8):956-60. PubMed ID: 12686335
[TBL] [Abstract][Full Text] [Related]
36. Intensive combination drug therapy of familial hypercholesterolemia with lovastatin, probucol, and colestipol hydrochloride.
Witztum JL; Simmons D; Steinberg D; Beltz WF; Weinreb R; Young SG; Lester P; Kelly N; Juliano J
Circulation; 1989 Jan; 79(1):16-28. PubMed ID: 2642754
[TBL] [Abstract][Full Text] [Related]
37. Long term-effect of fenofibrate on lipoprotein level and composition in different types of genetic hyperlipidemias.
Baggio G; Gasparotto A; Ciuffetti G; Valerio G; Fellin R; Senin U; Gabelli C; Crepaldi G
Pharmacol Res Commun; 1986 May; 18(5):471-80. PubMed ID: 3737657
[TBL] [Abstract][Full Text] [Related]
38. Lipoproteins, HDL-apolipoproteins, activities of hepatic lipase and lecithin-cholesterol acyltransferase in the plasma of patients with post-alcoholic end-stage liver cirrhosis.
Breier C; Lisch HJ; Braunsteiner H
Klin Wochenschr; 1983 Sep; 61(18):929-31. PubMed ID: 6632732
[TBL] [Abstract][Full Text] [Related]
39. In vitro production of beta-very low density lipoproteins and small, dense low density lipoproteins in mildly hypertriglyceridemic plasma: role of activities of lecithin:cholester acyltransferase, cholesterylester transfer proteins and lipoprotein lipase.
Chung BH; Segrest JP; Franklin F
Atherosclerosis; 1998 Dec; 141(2):209-25. PubMed ID: 9862170
[TBL] [Abstract][Full Text] [Related]
40. Preheparin lipoprotein lipolytic activities: relationship to plasma lipoproteins and postheparin lipolytic activities.
Glaser DS; Yost TJ; Eckel RH
J Lipid Res; 1992 Feb; 33(2):209-14. PubMed ID: 1569373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
